
Chennakesava Cuddapah
Fähigkeiten und Kenntnisse
Werdegang
Berufserfahrung von Chennakesava Cuddapah
- Bis heute 6 Jahre, seit Juli 2019
CEO/BDO/Founder
Curio Biotech Ltd
- 2 Jahre und 6 Monate, Jan. 2017 - Juni 2019
Founder, Scientific & Business Development Manager
Curio Biotech Ltd
- 4 Jahre und 8 Monate, Aug. 2011 - März 2016
Manager for Contract Research and R&D
Cellntec Advanced Cell systems
Invitro testing for cosmetic and biotech industries using human primary cell cultures and 3D models (with cell types such as primary keratinocytes, fibroblasts, melanocytes and adipocytes derived from human skin).
- 2010 - 2011
Research Associate
Kantonsspital Aaarau
1. Immunobiology of citrunillated antigens and antibodies in human autoimmune disease Rheumatoid Arthritis (in human neutrophils, serum and plasma) Techniques: Antibody purification, ELISA development, protein purification and processing for Mass spectrometric analysis, isolation of neutrophils from synovial fluid cells
- 2007 - 2009
Research Associate
Fred Hutchinson Cancer Research Center
1. Immune function of microchimeric cells in human autoimmune disease Systemic Sclerosis/Scleroderma and Transplantation. (in human cell types such as primary skin micro-vascular endothelial cells, T & B lymphocytes, granulocytes, human bone marrow cells and in human tissues such as skin and lung) 2. HLA genetics of human autoimmune disease Systemic Sclerosis/Scleroderma. (High resolution HLA genotyping)
- 2005 - 2007
Postdoctoral fellow
University Hospital Basel
Antigen (viral and endogenous) processing and presentation by human primary vascular endothelial cells and their recognition by cytotoxic T cell lymphocytes.
- 2 Jahre und 2 Monate, 2000 - Feb. 2002
Project Assistant
Indian Institute of Sciences
Development of male contraception: Identification of estrogen regulated genes in the epidydimis of Macaca radiata (Bonnet monkey) for the
Ausbildung von Chennakesava Cuddapah
- 2002 - 2005
Biology
University of Bern, Switzerland
During my doctoral thesis, I worked on the role of receptor tyrosine kinase EphB4 and its ligand EphrinB2 during normal human placental development (angiogenesis and vasculogeneis) and in placental disorder pre-eclampsia. (in human primary trophoblast epithelial cells, human primary umbilical cor
Sprachen
Englisch
Fließend
Deutsch
Grundlagen
XING Mitglieder mit ähnlichen Profilangaben
XING – Das Jobs-Netzwerk
Über eine Million Jobs
Entdecke mit XING genau den Job, der wirklich zu Dir passt.
Persönliche Job-Angebote
Lass Dich finden von Arbeitgebern und über 20.000 Recruiter·innen.
22 Mio. Mitglieder
Knüpf neue Kontakte und erhalte Impulse für ein besseres Job-Leben.
Kostenlos profitieren
Schon als Basis-Mitglied kannst Du Deine Job-Suche deutlich optimieren.